New research indicates that individuals who stop using blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who end traditional diet and exercise plans.
Findings released in a leading medical journal demonstrates that while obese individuals frequently drop a large proportion of their total mass while using the jabs, the weight returns at an estimated rate of 0.8 kg per month once they quit.
"Individuals purchasing these medications should be aware of the risk of fast weight regain when the medication concludes," stated expert Dr. Susan Jebb.
This pace of recovery suggests a return to pre-treatment mass in about a year and a half.
Comparing Approaches
The research, which examined 37 of studies involving over 9,000 of participants, compared the effects of the injectable medications with conventional dieting.
The team note that individuals who lose weight through lifestyle changes alone generally have a more gradual weight regain—approximately 0.1 kg a month—post-intervention.
Explaining the Fast Rebound
Experts believe the mode of action of the drugs explains the amplified regain.
The injections copy a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of the hormone concentrations several times higher than normal might result in the system to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' results in appetite is unsuppressed, making excessive eating much more probable."
A Lifelong Issue?
Health authorities advise the jabs for people with obesity-related health risks, alongside prescribed lifestyle changes.
Many experts argue that, considering the significant potential of weight regain, the treatment should be considered ongoing.
This view is reinforced by pharmaceutical companies, who note that the findings "underscore the persistent nature of excess weight," similar to managing conditions like diabetes.
Patient Experiences
People who have discontinued the jabs report a intense return of cravings.
"I experienced something flipping and you're instantly extremely hungry," described an individual.
This difficulty is worsened if patients have not established lasting dietary or behavioural changes during therapy.
Growing Use
Figures show that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with desire remaining high.
- Use is more common among women compared to men.
- The middle-aged age group shows the highest usage rates.
- A large proportion obtain the medications through private healthcare rather than the NHS.
Ultimately, experts caution that while these medications are potent agents for shedding pounds, they are not a magic solution and maintained weight loss hinges on integrated behavioural changes.